These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
79 related articles for article (PubMed ID: 2345801)
1. Topical cyclosporine administration in rabbits. Stokar LM; Burckart GJ; D'Souza M; Cohen B; Venkataramanan R Res Commun Chem Pathol Pharmacol; 1990 Apr; 68(1):117-20. PubMed ID: 2345801 [TBL] [Abstract][Full Text] [Related]
2. Topical application of cyclosporine on guinea pig allergic contact dermatitis. Nakagawa S; Oka D; Jinno Y; Takei Y; Bang D; Ueki H Arch Dermatol; 1988 Jun; 124(6):907-10. PubMed ID: 3270996 [TBL] [Abstract][Full Text] [Related]
3. Overview of a 10-year experience on methods and compositions for inducing site-specific immunosuppression with topical immunosuppressants. Hewitt CW; Black KS Transplant Proc; 1996 Apr; 28(2):922-3. PubMed ID: 8623464 [TBL] [Abstract][Full Text] [Related]
4. Ultrastructural and immunohistochemical study on the effect of topical cyclosporin A in the rabbit eye. Versura P; Cellini M; Zucchini PG; Caramazza R; Laschi R Cornea; 1989; 8(2):81-9. PubMed ID: 2653726 [TBL] [Abstract][Full Text] [Related]
5. The prolongation of skin allograft survival by topical use of cyclosporine A. Zhao XF; Schroeder TJ; Alexander JW; Miskell P; Gonce SJ; Babcock GF Transplant Proc; 1988 Apr; 20(2 Suppl 2):670-3. PubMed ID: 3284116 [TBL] [Abstract][Full Text] [Related]
6. Topically applied cyclosporine in azone prolongs corneal allograft survival. Newton C; Gebhardt BM; Kaufman HE Invest Ophthalmol Vis Sci; 1988 Feb; 29(2):208-15. PubMed ID: 3276643 [TBL] [Abstract][Full Text] [Related]
7. Suppression of secondary herpes simplex uveitis by cyclosporine. Oh JO; Minasi P; Grabner G; Ohashi Y Invest Ophthalmol Vis Sci; 1985 Apr; 26(4):494-500. PubMed ID: 2984138 [TBL] [Abstract][Full Text] [Related]
8. Suppressor cells in different types of unresponsiveness to dinitrochlorobenzene (DNCB) contact sensitivity in guinea pigs. Polk L Int Arch Allergy Appl Immunol; 1975; 49(1-2):281-4. PubMed ID: 1140858 [No Abstract] [Full Text] [Related]
9. Site-specific immunosuppression using a new formulation of topical cyclosporine A with polyethylene glycol-8 glyceryl caprylate/caprate. Tran HS; Malli D; Chrzanowski FA; Puc MM; Matthews MS; Hewitt CW J Surg Res; 1999 May; 83(2):136-40. PubMed ID: 10329107 [TBL] [Abstract][Full Text] [Related]
10. NTP Toxicology and Carcinogenesis Studies of Triethanolamine (CAS No. 102-71-6) in F344 Rats and B6C3F1 Mice (Dermal Studies). National Toxicology Program Natl Toxicol Program Tech Rep Ser; 1999 Nov; 449():1-298. PubMed ID: 12594526 [TBL] [Abstract][Full Text] [Related]
11. [Treatment of severe alopecia areata with topical applications of cyclosporin A]. Mauduit G; Lenvers P; Barthélémy H; Thivolet J Ann Dermatol Venereol; 1987; 114(4):507-10. PubMed ID: 3619297 [TBL] [Abstract][Full Text] [Related]
12. The effect on the cornea of alpha cyclodextrin vehicle for cyclosporin eye drops. Kanai A; Alba RM; Takano T; Kobayashi C; Nakajima A; Kurihara K; Yokoyama T; Fukami M Transplant Proc; 1989 Feb; 21(1 Pt 3):3150-2. PubMed ID: 2705275 [TBL] [Abstract][Full Text] [Related]
14. A preliminary pharmacokinetic study of cyclosporine A in 10 Japanese renal transplant patients. Takada K; Yoshikawa H; Muranishi S; Nagano S; Fukunishi T Int J Clin Pharmacol Ther Toxicol; 1987 Aug; 25(8):438-42. PubMed ID: 3308718 [TBL] [Abstract][Full Text] [Related]
15. Final report on the safety assessment of capsicum annuum extract, capsicum annuum fruit extract, capsicum annuum resin, capsicum annuum fruit powder, capsicum frutescens fruit, capsicum frutescens fruit extract, capsicum frutescens resin, and capsaicin. Int J Toxicol; 2007; 26 Suppl 1():3-106. PubMed ID: 17365137 [TBL] [Abstract][Full Text] [Related]
16. Effects of oral versus topical administration of cyclosporine on phorbol ester promotion of murine epidermal carcinogenesis. Yokota K; Gill TJ; Shinozuka H Cancer Res; 1989 Aug; 49(16):4586-90. PubMed ID: 2501029 [TBL] [Abstract][Full Text] [Related]
17. The plasma time course of orally-administered cyclosporine in the dog. Buice RG; Gurley BJ; Sidhu P Res Commun Chem Pathol Pharmacol; 1985 Oct; 50(1):143-6. PubMed ID: 4081308 [TBL] [Abstract][Full Text] [Related]
18. Evaluation of appropriate blood level in continuous intravenous infusion from trough concentrations after oral administration based on area under trough level in tacrolimus and cyclosporine therapy. Nakamura Y; Takeuchi H; Okuyama K; Akashi T; Jojima Y; Konno O; Akashi I; Hama K; Iwahori T; Ashizawa T; Hirano T; Oka K; Matsuno N; Nagao T Transplant Proc; 2005 May; 37(4):1725-7. PubMed ID: 15919445 [TBL] [Abstract][Full Text] [Related]
19. Effect of millimeter waves on cyclophosphamide induced suppression of the immune system. Logani MK; Anga A; Szabo I; Agelan A; Irizarry AR; Ziskin MC Bioelectromagnetics; 2002 Dec; 23(8):614-21. PubMed ID: 12395417 [TBL] [Abstract][Full Text] [Related]
20. Effects of cyclosporine A on clinical and immunological parameters in herpes simplex keratitis. Meyers-Elliott RH; Chitjian PA; Billups CB Invest Ophthalmol Vis Sci; 1987 Jul; 28(7):1170-80. PubMed ID: 3036742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]